“It wasn’t that they were taking higher or lower doses, but that they were taking it, which does speak to this idea of dampening inflammation,” said Nate Chin, MD, medical director for the Alzheimer’s Disease Research Center and the Wisconsin Registry for Alzheimer’s Prevention at the University of Wisconsin-Madison.
Office of Strategic Communication